Skip to main content

Antoni Vilaseca, MD

Antoni Vilaseca, MD, Hospital Clínic de Barcelona
Videos
11/01/2023
Antoni Vilaseca, MD, discusses the novel erdafinitib delivery system for patients with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations.
Antoni Vilaseca, MD, discusses the novel erdafinitib delivery system for patients with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations.
Antoni Vilaseca, MD, discusses...
11/01/2023
Oncology